Company Profile
Competitive Advantages
Company Structure
Careers
Directors
Ms Deborah Ambrosini
Mr Greg Gilbert
Mr Hock Goh
Mr David Breeze
Investments
Advent Energy Limited
Cancer Therapeutics
ASX Releases
Published Media
Papers
Scientists Profile
Visual Media
Grants
Current Partners
Cortical Dynamics
Visual Media
Current Partners
Clinical Trials, Grants and Awards
Scientists' Profile's
Papers
Published Media
ASX Releases
Partnering Opportunities
Diagnostic Array Systems
Partners
Grants
Scientists' Profiles
Papers
Visual Media
Published Media
ASX Releases
Partnering Opportunities
HLS5
Current Partners
Grants
Visual Media
Scientists' Profiles
Papers
Published Media
ASX Releases
Partnering Opportunities
Molecular Discovery Systems
Partners
Grants
Visual Media
Scientists' Profile
Presentations
Papers
Published Media
ASX Releases
Partnering Opportunities
SERS Nanoprobes
Current Partners
Grants
Visual Media
SERS Scientists' Profiles
Published Media
Papers
ASX Releases
Partnering Opportunities
Upcoming Events
Past Events
News
Investor Relations
All Announcements
Partnering
Links
Contact Us
Staff Email Directory
All Announcements
August 2010
BPH Shareholder Update
July 2010
BPH to engage in Melanoma Drug Discovery
July 2010
Cortical Dynamics Paper Published in Anesthesiology Journal
July 2010
Cortical Dynamics Australian Patent Granted
July 2010
Advent Energy Announcement Clarification
July 2010
Advent Energy Update
June 2010
BPH Corporate Update on the HLS5 Tumor Suppressor Gene
June 2010
Expiry of Quoted Options - BPHO
May 2010
Technical CSIRO Study Update for BPH investee Advent Energy
May 2010
Cortical Dynamics Completes Functionality Trial
May 2010
BPH Corporate - 2010 BIO International Convention
May 2010
Cortical Dynamics ANZCA Poster
April 2010
Advent Energy Contracts Drilling Rig for PEP11
April 2010
Advent Energy Fudning Update
April 2010
Advent Energy PEP11 Site Survey Update
April 2010
Advent Energy Investment Update
March 2010
Anti-microtubule Cancer Therapeutics Update
March 2010
BPH Corporate Presentation
March 2010
Advent Energy Update - PEP11 Site Survey
March 2010
BPH Corporate Results of 2010 General Meeting
March 2010
Cortical Dynamics to present at the Australian and New Zealand College of Anaesthetists (ANZCA) and Faculty of Pain Medicine
February 2010
Advent Energy Limited - PEP 11 Operational Update
February 2010
Advent Energy Limited - PEP 11 Update
January 2010
Results of 2009 Annual General Meeting
January 2010
BPH Placement
January 2010
BPH Initiates Investment Option
December 2009
Cortical Dynamics Successfully Completes NHMRC Grant
December 2009
Allocation of Placement
December 2009
Results of 2009 General Meeting
December 2009
Change of Name to BPH Corporate Limited
December 2009
BioPharmica Limited Completes Capital Raising
November 2009
BioPharmical Limited Notice of General Meeting - Amended Indicative Timetable
November 2009
BioPharmica Notice of General Meeting - Amended Indicative Timetable
November 2009
Extension of Time to Hold 2009 Annual General Meeting
November 2009
Hls5 to be presented at the 51st ASH Annual Meeting
November 2009
NHMRC $608,500 Grant for HLS5
November 2009
Update - BioPharmica Limited 2009 Annual General Meeting
October 2009
Molecular Discovery Systems Spin Off and IPO
September 2009
Completion of Shareholder Share Purchase Plan
September 2009
Extension of Shareholder Share Purchase Plan
September 2009
BioPharmica Signs Option Deed with Advent Energy
September 2009
Advent Energy Limited Lodges EPBC Act Referrals
September 2009
New IPO for BioPharmica
September 2009
Advent Investment Opportunity
August 2009
Anti-Mitotic Project Update
August 2009
BioPharmica Confirms 100% Ownership of New Anti Cancer Agents
August 2009
US Patent Granted for HLS5
August 2009
Promising Results for Cortical Dynamics
June 2009
Cortical Dynamics Project Update
May 2009
NZ Patent Granted for Cortical Dynamics
May 2009
HLS5 Project Awarded Grant for Melanoma Research
March 2009
Molecular Discovery Systems High Content Screening Service
March 2009
Novel Cancer Therapeutic Discovery
February 2009
Half Yearly Financial Report December 2008
February 2009
HLS5 presented at the 21st Lorne Cancer Conference 2009
January 2009
Diagnostic Array Systems Complete Grant for the BacTrak System
November 2008
BioPharmica Ltd Annual Report 2008
October 2008
International Publication Milestone for BAR Monitor
September 2008
HLS5 at BIO2008
September 2008
HLS5 Presented at ComBio 2008 in Canberra
September 2008
New Drug - Cancer Impact
July 2008
Genes Identified in a Hemopoietic Lineage Switch Influence Transcription
June 2008
HLS5 Screening yields New Drug Leads
May 2008
HLS5 Conference Coverage - Leave it to the Master Gene
April 2008
Fujikura and BioPharmica Sign Collaboration Agreement
April 2008
BioPharmica and GE Healthcare Collaboration Completion
February 2008
International HLS5 Scientific Publication
December 2007
Encouraging Trial Results for Monitoring Brain Function
October 2007
MDSystems Image Analysis Used to Help Publish Technique Article
October 2007
Cortical Dynamics Update
August 2007
BioPharmica Ltd Notice of Meeting - Indicative Timetable
June 2007
BioPharmica Investee Wins Commercial Grant
July 2007
ABC TV Coverage on Cortical Dynamics
July 2007
Re: Clarification of Shareholder Share Purchase Pland and Proposed Cortical Dynamics Spin-Off
July 2007
Re: BioPharmica Limited Shareholder Share Purchase Plan
July 2007
Invitation to participate - BioPharmica Share Purchase Plan
June 2007
BioPharmica to move to 83.5% in HLS5 investment
June 2007
GBA: IPO intention for BioPharmica Ltd
June 2007
New IPO intended for BioPharmica
May 2007
BAR Monitoring System Features on ABC Catalyst Program
May 2007
BioPharmica Limited Joint Venture Patents as at 7 May 2007
May 2007
HLS5 Tumour Suppressor Gene - Developments Update
March 2007
NHMRC Grant Funding Awarded to BioPharmica Project
March 2007
SERS Probe in Commercial Development Agreement
March 2007
Cell-Based imaging for tissue samples - Australian Biotechnology News
December 2006
Australian Bacterial DNA Test Success
November 2006
BioPharmica and GE Healthcare Collaboration Update
October 2006
BioPharmica in GE Healthcare Collaboration - Shareholder Letter
October 2006
BioPharmica in GE Healthcare Collaboration
September 2006
BPH secures "Tumour Suppressor Factor" Patent number 784629
June 2006
Australian Technology to Monitor Brain Function in Clinical Trials
May 2006
Successful Brain Function Monitor Results
May 2006
Uni California Expert to Work with MDS on Image Analysis
April 2006
Launch of Molecular Discovery Systems
February 2006
Successful Lung Disease Genechip Trial
January 2006
Lung Disease Test Results Update
January 2006
Bacterial Genechip Trial Completed
January 2006
HLS5 Gene implicated in Huntington's and AIDS
September 2005
BAR Monitor Validation Trials
September 2005
HLS5 Gene Project Update
May 2005
Successful HLS5 Cancer Gene Pre-clinical Trial
March 2005
BAR System Passes International EMC Testing
February 2005
BioPharmica Cancer Gene Pilot Trial
January 2005
Cancer expert joins BioPharmica HLS5 Reserach Team
December 2004
New Anaesthesia Monitoring Trial at Royal Melbourne Hospital
December 2004
RMIT University Bacterial Research Agreement
November 2004
Federal Gov Funds BioPharmica DAS Project
November 2004
Scientists Win Grant Recognition
September 2004
Swinburne Uni and BioPharmica Biotech Agreement
September 2004
Brain Science Company Signs with BioPharmica
September 2004
BioPharmica Cancer Gene Progress
September 2004
BioPharmica Prototype and Pilot Test
Email Subscription
Enter your email address below to receive our email updates
Latest News
Feed